BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19013338)

  • 1. Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.
    Garnacho-Montero J; Díaz-Martín A; Cayuela-Dominguez A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S137-41. PubMed ID: 19013338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of invasive candidiasis with echinocandins.
    Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
    Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin for the prophylaxis and treatment of Candida infections.
    Fritz JM; Brielmaier BD; Dubberke ER
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinocandins: pharmacokinetic and therapeutic issues.
    Cleary JD
    Curr Med Res Opin; 2009 Jul; 25(7):1741-50. PubMed ID: 19557937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungals in the ICU.
    Playford EG; Eggimann P; Calandra T
    Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida prophylaxis and therapy in the ICU.
    Echeverria PM; Kett DH; Azoulay E
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
    Sun HY; Singh N
    Int J Antimicrob Agents; 2010 Mar; 35(3):211-8. PubMed ID: 20036518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical review of echinocandins in pediatric patients.
    VandenBussche HL; Van Loo DA
    Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinocandins: a wealth of choice--how clinically different are they?
    Zaas AK
    Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of critically ill patients with candidemia.
    Mensa J; Pitart C; Marco F
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S93-7. PubMed ID: 19013347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
    BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Invasive candidiasis in critically ill patients].
    Eggimann P; Pittet D
    Schweiz Med Wochenschr; 2000 Oct; 130(42):1525-37. PubMed ID: 11092055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive fungal infections in patients after liver transplantation].
    Fischer L; Sterneck M
    Mycoses; 2005; 48 Suppl 1():27-35. PubMed ID: 15826284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
    Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.